Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arcturus Therapeutics Ltd (ARCT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Arcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders

All Four Proposals Approved by Shareholders

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics to Present at the JMP Securities Life Sciences Conference

Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that it plans to present at the JMP Securities Life Sciences Conference on Thursday, June 21, in New York City....

ARCT : 8.34 (-1.77%)
Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO

Industry veteran Dr. Peter Farrell named as Chairman of the Board, Dr. Pad Chivukula reinstated as CSO and COO

RMD : 109.33 (+0.48%)
ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders

Arcturus Therapeutics Ltd. ("Arcturus" or the "Company") (NASDAQ:ARCT), an RNA medicines company, today announced that the Extraordinary General Meeting of the Shareholders of the Company that was announced...

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Founder Joseph Payne Calls for an End to Company's Frivolous and Costly Lawsuits; Applauds Court Decision and Welcomes June 25, 2018 EGM Date

-- Welcomes Israeli Court order that forced Arcturus Board to set date for Extraordinary General Meeting ("EGM") of shareholders for June 25, 2018

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders

Board of Directors Recommends Removal of Terminated CEO Joseph Payne from Board of Directors

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Files Form 20-F

Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced the filing of the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2017 with the U.S....

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary General Meeting to Vote for New Board Members

-- The Extraordinary General Meeting to be scheduled between June 18 and June 24, 2018

ARCT : 8.34 (-1.77%)
Blog Exposure - Arcturus Initiates Lawsuit against Former CEO Joseph Payne for Misconduct and Violations of Federal Disclosure

Stock Monitor: PLx Pharma Post Earnings Reporting

PLXP : 3.95 (-0.25%)
ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Founder Joseph Payne Dismisses Board's Baseless Lawsuit as Desperate Entrenchment Tactic

-- Warns lawsuit is another attempt by Arcturus' board to distract shareholders from the Company's abhorrent governance deficiencies

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Files Lawsuit Against Joseph E. Payne and His Associates for Violations of Federal Securities Laws

Complaint Details Multiple Violations of Federal Securities Laws by Undisclosed Group Led by Payne

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Founder Joseph Payne Disappointed by Board's Desperate Attempt to Delay Meeting and Avoid Shareholder Accountability

-- Change in Arcturus board is needed on an urgent basis to improve the company's performance

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Issues Statement Regarding Timing of Extraordinary General Meeting of Shareholders

Postponement due to Joseph Payne's Focus on Advancing His Personal Agenda at the Expense of Arcturus Shareholders

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Issues Open Letter to Shareholders

Details Former President and CEO Joseph E. Payne's Poor Judgment, Failed Leadership and Deceit that Led to His Termination for Cause

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Initiates Lawsuit Against Joseph E. Payne to Protect the Interests of Arcturus Shareholders

Complaint Details Extensive Misconduct by Mr. Payne during Tenure as CEO

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders

Board of Directors Recommends Removal of Terminated CEO Joseph Payne from Board of Directors

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach

Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today issued the following statement regarding the previously announced process for members of the Company's Board of Directors...

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Issues Statement Regarding Extraordinary General Meeting of Shareholders

Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that, based on the preliminary vote count provided by its transfer agent following Arcturus' extraordinary general...

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Comments on Amended 13D Filing

Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today commented on the amended 13D filing by Joseph E. Payne, who was fired from Arcturus as of February 1, 2018, for conduct...

ARCT : 8.34 (-1.77%)
Arcturus Therapeutics Appoints Dr. Christine Esau as Vice President of Research and Development

Dr. Pad Chivukula Resigns as Chief Scientific Officer and Chief Operating Officer

ARCT : 8.34 (-1.77%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC -0.38 , FTNT +0.53 , CAKE -0.45 , PLT -0.28 , AEO -0.65
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the week with most contracts 3 to 4 cents higher on Friday. Nearby September was up 4.1% since last Friday, with higher closes every day this week. Solid exports and drier weather fueled some bottom picking and short covering acti...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar